Teladoc Health, Inc.
General ticker "TDOC" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $1.5B (TTM average)
Teladoc Health, Inc. follows the US Stock Market performance with the rate: 19.5%.
Estimated limits based on current volatility of 2.1%: low 7.42$, high 7.74$
Factors to consider:
- Total employees count: 5500 (-1.8%) as of 2024
- US accounted for 84.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Net losses and accumulated deficit, Customer relationships, Cybersecurity threats, Regulatory and compliance, Strategic risks and growth management
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [5.42$, 14.87$]
- 2025-12-31 to 2026-12-31 estimated range: [4.57$, 12.76$]
Financial Metrics affecting the TDOC estimates:
- Negative: with PPE of -7.5 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 18.53 > 13.24
- Positive: 41.86 < Shareholder equity ratio, % of 42.40 <= 63.39
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
Short-term TDOC quotes
Long-term TDOC plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $2,406.84MM | $2,602.41MM | $2,569.57MM |
| Operating Expenses | $16,060.05MM | $2,850.97MM | $3,590.46MM |
| Operating Income | $-13,653.21MM | $-248.55MM | $-1,020.89MM |
| Non-Operating Income | $-10.13MM | $28.95MM | $27.23MM |
| Interest Expense | $9.27MM | $22.28MM | $23.80MM |
| R&D Expense | $333.63MM | $348.52MM | $307.27MM |
| Income(Loss) | $-13,663.34MM | $-219.61MM | $-993.65MM |
| Taxes | $-3.81MM | $0.76MM | $7.59MM |
| Profit(Loss)* | $-13,659.53MM | $-220.37MM | $-1,001.25MM |
| Stockholders Equity | $2,307.74MM | $2,326.07MM | $1,491.08MM |
| Inventory | $56.34MM | $29.51MM | $38.14MM |
| Assets | $4,700.95MM | $4,392.37MM | $3,516.52MM |
| Operating Cash Flow | $189.29MM | $350.02MM | $293.68MM |
| Capital expenditure | $16.48MM | $156.35MM | $10.79MM |
| Investing Cash Flow | $-167.74MM | $-156.35MM | $-124.05MM |
| Financing Cash Flow | $6.50MM | $10.85MM | $8.31MM |
| Earnings Per Share** | $-84.60 | $-1.36 | $-5.87 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.